TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Macopharma Nordic AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
38,211
|
45,497
|
52,156 |
Financial expenses |
288
|
712
|
137 |
Earnings before taxes |
61
|
1,077
|
974 |
EBITDA |
3,619
|
4,561
|
2,650 |
Total assets |
20,022
|
24,829
|
22,918 |
Current assets |
10,788
|
14,115
|
13,949 |
Current liabilities |
5,205
|
6,432
|
8,415 |
Equity capital |
14,047
|
13,987
|
13,883 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
8
|
9
![]() |
9 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
70.2%
|
56.3%
|
60.6% |
Turnover per employee |
4,776
|
5,055
|
5,795 |
Profit as a percentage of turnover |
0.2%
|
2.4%
|
1.9% |
Return on assets (ROA) |
1.7%
|
7.2%
|
4.8% |
Current ratio |
207.3%
|
219.4%
|
165.8% |
Return on equity (ROE) |
0.4%
|
7.7%
|
7.0% |
Change turnover |
-7,286
|
-6,659
|
1,732 |
Change turnover % |
-16%
|
-13%
|
3% |
Chg. No. of employees |
-1
|
0
![]() |
0 |
Chg. No. of employees % |
-11%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.